Keywords: Australia, Similar biologics, Biosimilars, Reimbursement, PIC

Australia's PIC reports to Ministers on treatment and reimbursement of similar biologics

Article | 14 June 2012

The Australian Pharmaceuticals Industry Council (PIC), with industry group members AusBiotech, Medicines Australia and the GMiA (representing generic drugmakers), has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in